Updated:
Forty Seven, Inc.
Forty Seven, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001667633, and its reported industry is...
Overview
Forty Seven, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001667633, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2020-03-20, it reported annual revenue of USD 15,678,000; net income of USD -87,621,000; total assets of USD 343,593,000 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Forty Seven, Inc.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Menlo Park, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001667633
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2019USD | $15.7M | -$87.6M | $343.6M | $213.8M | -$78.1M | |
| FY2018USD | — | -$70.4M | $149.4M | $10.8M | -$66.0M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| SC 13G | — | SCHEDULE 13G | |
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | FTSV 8K EARNINGS RELEASE Q3 2019 | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Forty Seven, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.